Background: How GLP-1s evolved from diabetes treatment to anti-obesity medications Glucagon-like peptide-1 receptor agonists (GLP-1s) have a notable history in medical treatment, beginning as therapies for type 2 diabetes and later emerging as highly effective agents for weight loss
The Drug Enforcement Administrations 2025 National Drug Threat Assessment reports larger seizures of methamphetamine pills disguised as Adderall or MDMA and notes that the anesthetic medetomidine has been found mixed with xylazine and fentanyl in powders and pills
Pair with Structured Training Two to three weekly sessions of compound lifts (squats, deadlifts, presses)
Pastural E, Ritchie S, Lu Y, Jin W, Kavianpour A, Khine Su-Myat K, Heath D, Wood PL et al (2009) Novel plasma phospholipid biomarkers of autism: mitochondrial dysfunction as a putative causative mechanism